Filing Details

Form Type:
4
Zero Holdings:
No
Publication Time:
2009-01-05 05:08:37
Reporting Period:
2008-12-31
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Biosante Pharmaceuticals Inc BPAX ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238120 B Philip Donenberg 111 Barclay Blvd
Suite 280
Lincolnshire IL 60069
No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2008-12-31 3,000 $1.00 40,322 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct